Guidelines for phase 1 clinical trials | |||
---|---|---|---|
분류 | Clinical Trial, Guidance | 조회 | 2393 |
발행년도 | 2012 | 등록일 | 2015-10-02 |
출처 | abbi (바로가기) | ||
The development of new and better medicines is vital for the public health. A key step in medicines development is the transition from the laboratory to the human subject in a phase 1 clinical trial, when potential new medicines are given to humans for the first time.
(후략)
|
|
이전글 | COMPLIANCE POLICY GUIDE RADIOPHARMACEUTICAL COMPOUNDING |
---|---|
다음글 | Guidance FDA Oversight of PET Drug Products Questions and Answers |